The inaugural article in this domain was published in 2010 in Clinical Cancer Research by Ahmed and Nabil, titled “HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors”. This evidence concerns the gene ERBB2 and cancer.